Meeting
2014 ASCO Annual Meeting
Randomized phase II study with dendritic cell (DC) immunotherapy in patients with resected hepatic metastasis of colorectal carcinoma.
Authors
Javier Rodriguez
Medical Oncology, Clinica Universidad de Navarra, Pamplona, Spain
Javier Rodriguez , Ruth Vera , Fernando Pardo , Javier Herrera , Ana Chopitea , Irene Hernandez , Antonio Viudez , Carlos Garzon , Carlos Alfaro , Jose Luis Perez-Gracia , Alberto Benito , Alvaro Gonzalez , Ivan Peñuelas , Maria Rodriguez-Ruiz , Miguel F. Sanmamed , Carmen Oñate , Carmen Ochoa , Juan Pablo Fusco , Ignacio Melero
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics - Immunotherapy
Track
Developmental Therapeutics
Sub Track
Vaccines
Clinical Trial Registration Number
NCT01348256
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr TPS3129)
DOI
10.1200/jco.2014.32.15_suppl.tps3129
Abstract #
TPS3129
Poster Bd #
187A
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Phase II study with immunotherapy with dendritic cells (DC) and intratumoral hiltonol in patients with advanced solid tumors.
First Author: José María López-Picazo
Poster
2023 ASCO Annual Meeting
Molecular and clinical correlates of DSCR1 expression in pancreatic cancer (PDAC).
First Author: Francesca Battaglin
Poster
2023 ASCO Annual Meeting
Comprehensive profiling of clock genes expression in hepatocellular carcinoma (HCC).
First Author: Francesca Battaglin
Poster
2023 ASCO Gastrointestinal Cancers Symposium
HCRN GI16-288: A phase II trial of perioperative CV301 vaccination in combination with nivolumab and systemic chemotherapy for resectable hepatic-limited metastatic colorectal cancer—Preliminary efficacy and correlative results.
First Author: Kristen Renee Spencer